LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients

Therapies targeting SRC family kinases (SFKs) have shown efficacy in treating non-small cell lung cancer (NSCLC). However, recent clinical trials have found that the SFK inhibitor dasatinib is ineffective in some patient cohorts. Regardless, dasatinib treatment may benefit some NSCLC patient subgrou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Kim, Yu Jin, Hong, Sungyoul, Sung, Minjung, Park, Min Jeong, Jung, Kyungsoo, Noh, Ka-Won, Oh, Doo-Yi, Lee, Mi-Sook, Oh, Ensel, Shin, Young Kee, Choi, Yoon-La
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347739/
https://ncbi.nlm.nih.gov/pubmed/27756880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12657
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados